Navigation Links
ARIUS Announces Third Quarter Fiscal 2007 Financial Results
Date:10/12/2007

-----------------

Cash provided by (used in):

Operating activities:

Loss for the period (2,761,874) (1,469,728) (29,581,295)

Items not involving cash:

Amortization of:

Property and equipment 108,151 85,426 1,163,788

Deferred costs - 14,364 55,055

Leasehold inducements (10,371) - (45,781)

Loss on disposal of equipment - - 23,532

Write-off of leasehold

improvements - - 86,349

Leasehold inducement - - 89,148

Non-cash stock-based

compensation 266,197 31,456 1,486,216

Accretion of convertible

debentures - 120,903 429,905

Loss on extinguishment of debt - - 782,143

Services received for common

shares - - 400,024

Write-off of investment - - 20,000

Interest expense paid in

common shares - - 140,032

-----------------------------------------------------------------------

(2,397,897) (1,217,579) (24,950,884)

Change in non-cash operating

working capital items 638,007 (110,711) 4,041,306

-----------------------------------------------------------------------

(1,759,890) (1,328,290) (20,909,578)

Financing activities:

Issue of shares, warrants and

units, net of issuance costs - - 38,281,778

Issuance of convertible bridge

loan, net
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Streptococcus salivarius
2. Streptococcus salivarius
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015  New Jersey Health Foundation, a not-for-profit ... state of New Jersey , has ... funding, announced James M. Golubieski , president. ... Grants program, an additional $500,000 will be available for ... stage research projects that demonstrate exciting potential and may ...
(Date:3/30/2015)... ROCKVILLE, Md. , March 30, 2015 ... company dedicated to the acquisition, development and commercialization of ... for the global market with a commercial focus on ... China Food and Drug Administration (CFDA) has approved the ... trial in ovarian clear cell carcinoma (OCCC) patients for ...
(Date:3/30/2015)... 30, 2015    Intrexon Corporation (NYSE: ... and Merck Serono, the biopharmaceutical business of Merck ... announced an exclusive strategic collaboration and license agreement ... (CAR-T) cancer therapies. This collaboration advances Merck Serono,s ... modulate the immune system,s natural ability to fight ...
(Date:3/30/2015)... (PRWEB) March 29, 2015 A two-day ... United States and plenary talks by four leading photonics ... Optics + Optoelectronics next month in Prague, Czech ... in 17 conferences alongside a two-day exhibition. Sponsored by ... , the event will run 13-16 April in the ...
Breaking Biology Technology:New Jersey Health Foundation Announces An Additional $1 Million To Fund Innovation and Research Grants in New Jersey 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3
... Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN ) ... SCORPION(TM) multispecific therapeutic technology at the 100th Annual ... (AACR) in Denver. The data presented demonstrated the ... SCORPION molecule, its differentiation from monospecific approaches, and ...
... demonstrates company,s commitment to sustainabilityLAS VEGAS, April 22 ... commitment to protecting tomorrow today through its sustainability ... Region for Bayer CropScience, presented Tom Lovelace, United ... million endowment over the next four years to ...
... Cohen to be inducted into National Academy of Sciences for ... Sir Philip Cohen of Scotland,s University of Dundee ... (NAS) during its 146th annual meeting on Saturday, April 25 ... in original scientific research. Sir Philip is one of only ...
Cached Biology Technology:Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting 3Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting 4Bayer CropScience Donates $1.1 Million to United Fresh Research & Education Foundation to Create the Center for Global Produce Sustainability 2Bayer CropScience Donates $1.1 Million to United Fresh Research & Education Foundation to Create the Center for Global Produce Sustainability 3Bayer CropScience Donates $1.1 Million to United Fresh Research & Education Foundation to Create the Center for Global Produce Sustainability 4United States Recognizes Leading Scottish Scientist for Disease Research 2
(Date:3/18/2015)... CORAL SPRINGS, Florida , March 18, 2015 ... as well as businesses, new revolutionary smart wallets and apps ... rapid pace.  Companies currently entrenched in the mobile payment industry ... ), Alibaba Group Holding Ltd. (NYSE: BABA ), ... GOOG ) and Facebook Inc. (NASDAQ: ...
(Date:3/12/2015)... March 12, 2015 IriTech, a leading iris ... of the Texas Instruments Design Network, announced today that ... demonstrated its IriShield USB MK2120U device during a launching ... pension distribution. The iris scanner is ... marketed in India through its ...
(Date:3/11/2015)... 11, 2015   The Sync Project™ ... scientifically measure and harness music to improve health. ... and objective measurements of physiology, enabling the study ... in large populations. It is designed for medical ... perform rigorous studies and accelerate the discovery of ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... of studies reporting estimates of the prevalence of sexually ... past 20 years suggests that a considerable burden of ... (before birth) facilities in sub-Saharan Africa, according to a ... May 16 issue of JAMA , a theme ...
... Ore. (May 15, 2012)Twenty-six scientists have received a total ... Foundation to study psoriasisthe most common autoimmune disease in ... psoriatic arthritis, an inflammatory joint and tendon disease. ... Discovery Grant, for a total of $400,000, for pilot ...
... Tall, waving corn fields that line Midwestern roads may ... less water, fertilizer and other inputs, thanks to a ... a Purdue University assistant professor of plant biochemical and ... steroid function in corn plants would create tiny versions ...
Cached Biology News:Considerable prevalence of both malaria, STIs exist among pregnant women in sub-Saharan Africa 2National Psoriasis Foundation awards more than $2 million for research 2Tiny plants could cut costs, shrink environmental footprint 2
... Customer Peptide Synthesis , 20 Amino Acid length max ... 20 mg will return to customer for future usage conjugation of ... , Maintenance 102 days/each , Pre-immune ... /each , Test bleed (app. 5 ml) x1 ...
Request Info...
... Immunogen: Synthetic peptide derived from ... junctophilin-1. Specificity: Specific for the ... controls: mouse brain and skeletal muscle ... muscle tissues). Applications: Western blotting ...
... R&D Systems adds two new Stem ... of stem cell products. The Human Embryonic ... SC008) contains the antibodies against: alkaline phosphatase, ... Embryonic Stem Cell Marker Antibody Panel Plus ...
Biology Products: